Patents Assigned to Ascletis BioScience Co., Ltd
  • Nucleoside derivatives and methods of use thereof
    Patent number: 11541071
    Abstract: Certain anti-viral compounds, pharmaceutical compositions, and methods related thereto are disclosed.
    Type: Grant
    Filed: May 20, 2022
    Date of Patent: January 3, 2023
    Assignee: Ascletis BioScience Co., Ltd
    Inventors: Bin Liang, Bailing Yang, Yang Lai, Jinzi Jason Wu